New insights into human Cryptosporidiosis

Clinical Microbiology Reviews

Volumn 12, Issue 4, 1999, Pages 554-563

  Clark, Douglas P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AZITHROMYCIN; NITAZOXANIDE; PAROMOMYCIN;

ANTIBIOTIC THERAPY; ANTIPROTOZOAL ACTIVITY; BIODIVERSITY; CLINICAL TRIAL; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; DRUG RESISTANCE; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; REVIEW;

CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM; HUMAN IMMUNODEFICIENCY VIRUS; PROTOZOA;

EID: 0032823158     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.12.4.554     Document Type: Review

References (155)

1. Adams, R. B., R. L. Guerrant, S. Zu, G. Fang, and J. K. Roche. 1994. Cryptosporidium parvum infection of intestinal epithelium: Morphologic and functional studies in an in vitro model. J. Infect. Dis. 169:170-177.
2. Agnew, D. G., A. A. M. Lima, R. D. Newman, T. Wuhib, R. D. Moore, R. L. Guerrant, and C. L. Sears. 1998. Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J. Infect. Dis. 177:754-760.
3. Aguirre, S. A., P. H. Mason, and L. E. Perryman. 1994. Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection. Infect. Immun. 62:697-699.
4. Argenzio, R. A., J. Lecce, and D. W. Powell. 1993. Prostanoids inhibit intestinal NaCl absorption in experimental porcine cryptosporidiosis. Gastroenterology 104:440-447.
5. Argenzio, R. A., J. A. Liacos, M. L. Levy, D. J. Meuten, J. G. Lecce, and D. W. Powell. 1990. Villous atrophy, crypt hyperplasia, cellular infiltration, and impaired glucose-Na absorption in enteric cryptosporidiosis of pigs. Gastroenterology 98:1129-1140.
6. Awad-El-Kariem, F. M., H. A. Robinson, D. A. Dyson, D. Evans, S. Wright, M. T. Fox, and V. M. McDonald. 1995. Differentiation between human and animal strains of Cryptosporidium parvum using isoenzyme typing. Parasitology 110:129-132.
7. Awad-El-Kariem, F. M., D. C. Warhurst, and V. McDonald. 1994. Detection and species identification of Cryptosporidium oocysts using a system based on PCR and endonuclease restriction. Parasitology 109:19-22.
8. Balatbat, A. B., G. W. Jordan, Y. J. Tang, and J. J. Silva. 1996. Detection of Cryptosporidium parvum DNA in human feces by nested PCR. J. Clin. Microbiol. 34:1769-1772.
9. Blackman, E., S. Binder, C. Gaultier, R. Benveniste, and M. Cecilio. 1997. Cryptosporidiosis in HIV-infected patients: diagnostic sensitivity of stool examination, based on number of specimens submitted. Am. J. Gastroenterol. 92:451-453.
10. Blanshard, C., A. M. Jackson, D. C. Shanson, N. Francis, and B. G. Gazzard. 1992. Cryptosporidiosis in HIV-seropositive patients. Q. J. Med. 85:813-823.
11. Blunt, D. S., N. V. Khramtsov, S. J. Upton, and B. A. Montelone. 1997. Molecular karyotype analysis of Cryptosporidium parvum: evidence for eight chromosomes and a low-molecular-size molecule. Clin. Diagn. Lab. Immunol. 4:11-13.
12. Bobin, S., D. Bouhour, S. Durupt, A. Boibieux, V. Girault, and D. Peyramond. 1998. Value of protease inhibitors in the treatment of infections due to microsporidium and/or Cryptosporidium in patients with the HIV. Pathol. Biol. 46:418-419.
13. Bonnin, A., M. N. Fourmaux, J. F. Dubremetz, R. G. Nelson, P. Gobet, G. Harly, M. Buisson, D. Puygauthier-Toubsas, F. Gabriel-Pospisil, and M. Naciri. 1996. Genotyping human and bovine isolates of Cryptosporidium parvum by polymerase chain reaction-restriction fragment length polymorphism analysis of a repetitive DNA sequence. FEMS Microbiol. Lett. 137: 207-211.
14. Carr, A., D. Marriott, A. Field, E. Vasak, and D. A. Cooper. 1998. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 351:256-261.
15. Carraway, M., S. Tzipori, and G. Widmer. 1996. Identification of genetic heterogeneity in the Cryptosporidium parvum ribosomal repeat. Appl. Environ. Microbiol. 62:712-716.
16. Carraway, M., S. Tzipori, and G. Widmer. 1997. A new restriction fragment length polymorphism from Cryptosporidium parvum identifies genetically heterogeneous parasite populations and genotypic changes following transmission from bovine to human hosts. Infect. Immun. 65:3958-3960.
17. Centers for Disease Control and Prevention. 1995. Foodborne outbreak of diarrheal illness associated with Cryptosporidium parvum - Minnesota. Morbid. Mortal. Weekly Rep. 45:783-784.
18. Centers for Disease Control and Prevention. 1998. Foodborne outbreak of cryptosporidiosis - Spokane, Washington, 1997. Morbid. Mortal. Weekly Rep. 47:565-567.
19. Centers for Disease Control and Prevention. 1998. Outbreak of cryptosporidiosis associated with a water sprinkler fountain - Minnesota, 1997. Morbid. Mortal. Weekly Rep. 47:856-860.
20. Chaisson, R. E., J. E. Gallant, J. C. Keruly, and R. D. Moore. 1998. Impact of opportunistic disease on survival in patients with HIV infection. AIDS. 12:29-33.
21. Chappell, C. L., P. C. Okhuysen, C. R. Sterling, and H. L. DuPont. 1996. Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J. Infect. Dis. 173:232-236.
22. Checkley, W., R. H. Gilman, L. D. Epstein, M. Suarez, J. F. Diaz, L. Cabrera, R. E. Black, and C. R. Sterling. 1997. Asymptomatic and symptomatic cryptosporidiosis: their acute effect on weight gain in Peruvian children. Am. J. Epidemiol. 145:156-163.
23. + cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infect. Immun. 61:3928-3932.
24. Chen, W., J. A. Harp, A. G. Harmsen, and E. A. Havell. 1993. Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice. Infect. Immun. 61:3548-3551.
25. Chen, X. M., S. A. Levine, P. Tietz, E. Krueger, M. A. Mcniven, D. M. Jefferson, M. Mahle, and N. F. Larusso. 1998. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology 28:906-913.
26. Clark, D. P., and C. L. Sears. 1996. The pathogenesis of cryptosporidiosis. Parasitol. Today 12:221-225.
27. Colford, J. M., Jr., I. B. Tager, A. M. Hirozawa, G. F. Lemp, T. Aragon, and C. Petersen. 1996. Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival. Am. J. Epidemiol. 144:807-316.
28. Crabb, J. H. 1998. Antibody-based immunotherapy of cryptosporidiosis. Adv. Parasitol. 40:121-149.
29. Current, W. L. 1985. Cryptosporidiosis. JAMA 187:1334-1338.
30. Current, W. L., and L. S. Garcia. 1991. Cryptosporidiosis. Clin. Microbiol. Rev. 4:325-358.
31. Davis, L. J., R. E. Soave, R. E. Dudley, J. W. Fessel, S. Faulkner, and J. P. Mamaxos. 1996. Nitazoxanide (NTZ) for AIDS-related cryptosporidial diarrhea (CD): an open-label safety, efficacy and pharmacologic study, p. 289. In Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
32. Davis, R. W., R. W. Hyman, R. G. Nelson, and W. B. Strong. 15 March 1999, posting date. Sequences. [Online.| http://medsfgn.ucsf.edu/id/CpDemoProj/ index.html. [21 July 1999, last dale accessed.]
33. Doumbo, O., J. F. Rossignol, E. Richard, H. A. Traore, D. M. Diakite, F. Traore, and D. A. Diallo. 1997. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa. Am. J. Trop. Med. Hyg. 56:637-639.
34. Doyle, P. S., J. Kanaani, and C. C. Wang. 1998. Hypoxanthine, guanine, xanthine phosphoribosyltransferase activity in Cryptosporidium parvum. Exp. Parasitol. 89:9-15.
35. Dunand, V. A., S. M. Hammer, R. Rossi, M. Poulin, M. A. Albrecht, J. P. Doweiko, P. C. DeGirolami, E. Coakley, E. Piessens, and C. A. Wanke. 1997. Parasitic sinusitis and otitis in patients infected with human immunodeficiency virus: report of five cases and review. Clin. Infect. Dis. 25:267-272.
36. DuPont, H. L., C. L. Chappell, C. R. Sterling, P. C. Okhuysen, J. B. Rose, and W. Jakubowski. 1995. The infectivity of Cryptosporidium parvum in healthy volunteers. N. Engl. J. Med. 332:855-859.
37. Enriquez, F. J., C. R. Avila, J. I. Santos, J. Tanaka-Kido, O. Vallejo, and C. R. Sterling. 1997. Cryptosporidium infections in Mexican children: clinical, nutritional, enteropathogenic, and diagnostic evaluations. Am. J. Trop. Med. Hyg. 56:254-257.
38. Fayer, R., and B. L. P. Ungar. 1986. Cryptosporidium spp. and cryptosporidiosis. Microbiol. Rev. 50:458-483.
39. Feregriuno, G. M., R. F. Higuera, J. F. Rossignol, R. Cavier, C. Villarreal, O. J. Padierna, and H. Hidalgo. 1996. Extraordinary potency of the Nitozoxanida, a new antiparasitary against the Cryptosporidium infections in advanced AIDS, abstr. Th.B.4213. In XI International Conference on AIDS.
40. Fichtenbaum, C. J., D. J. Ritchie, and W. G. Powderly. 1993. Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS. Clin. Infect. Dis. 16:298-300.
41. Flanigan, T., C. Whalen, J. Turner, R. Soave, J. Toerner, D. Havlir, and D. Kotler. 1992. Cryptosporidium infection and CD4 counts. Ann. Intern. Med. 116:840-842.
42. Flanigan, T. P., B. Ramratnam, C. Graeber, J. Hellinger, D. Smith, D. Wheeler, P. Hawley, M. Heath-Chiozzi, D. J. Ward, and C. Brummitt. 1996. Prospective trial of paromomycin for cryptosporidiosis in AIDS. Am. J. Med. 100:370-372.
43. Foudraine, N. A., G. J. Weverling, T. van Gool, M. T. L. Roos, F. de Wolf, P. P. Koopmans, P. J. van den Broek, P. L. Meenhorst, R. van Leeuwen, and J. M. A. Lange. 1998. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS 12:35-41.
44. French, A. L., L. M. Beaudet, D. A. Benator, C. S. Levy, M. Kass, and J. M. Orenstein. 1995. Cholecystectomy in patients with AIDS: clinicopathologic correlations in 107 cases. Clin. Infect. Dis. 21:852-858.
45. Fricker, C. R., and J. H. Crabb. 1998. Water-borne cryptosporidiosis: detection methods and treatment options. Adv. Parasitol. 40:241-278.
46. Garcia, L. S., and R. Y. Shimizu. 1997. Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens. J. Clin. Microbiol. 35:1526-1529.
47. Gellin, B. G., and R. Soave. 1992. Coccidian infections in AIDS. Toxoplasmosis, cryptosporidiosis, and isosporiasis. Med. Clin. North Am. 76:205-234.
48. Genta, R. M., C. L. Chappell, J. A. C. White, K. T. Kimball, and R. W. Goodgame. 1993. Duodenal morphology and intensity of infection in AIDS-related intestinal cryptosporidiosis. Gastroenterology 105:1769-1775.
49. Gobet, P., J. C. Buisson, O. Vagner, M. Naciri, M. Grappin, S. Comparot, G. Harly, D. Aubert, I. Varga, and P. Camerlynck. 1997. Detection of Cryptosporidium parvum DNA in formed human feces by a sensitive PCR-based assay including uracil-N-glycosylase inactivation. J. Clin. Microbiol. 35:254-256.
50. Godwin, T. A. 1991. Crytosporidiosis in the acquired immunodeficiency syndrome: a study of 15 autopsy cases. Hum. Pathol. 22:1215-1224.
51. Goldstein, S., D. Juranek, O. Ravenholt, A. Hightower, D. Martin, J. Mesnik, S. Griffiths, A. Bryant, R. Reich, and B. Herwaldt. 1996. Cryptosporidiosis: an outbreak association with drinking water despite state-of-the-art water treatment. Ann. Intern. Med. 124:459-468.
52. Gomez Morales, M. A., C. M. Ausiello, A. Guarino, F. Urbani, M. I. Spagnuolo, C. Oignata, and E. Pozio. 1996. Severe, protracted intestinal cryptosporidiosis associated with interferon γ deficiency: pediatric case report. Clin. Infect. Dis. 22:848-850.
53. Goodgame, R. W., R. M. Genta, A. C. White, and C. L. Chappell. 1993. Intensity of infection in AIDS-associated cryptosporidiosis. J. Infect. Dis. 167:704-709.
54. Goodgame, R. W., K. Kimball, C.-N. Ou, J. A. C. White, R. M. Genta, C. H. Lifschitz, and C. L. Chappell. 1995. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 108:1075-1082.
55. Graczyk, T. K., M. R. Cranfield, and R. Fayer. 1996. Evaluation of commercial enzyme immunoassay (EIA) and immunofluorescent antibody (IFA) test kits for detection of Cryptosporidium oocysts of species other than Cryptosporidium parvum. Am. J. Trop. Med. Hyg. 54:274-279.
56. Griffiths, J. K. 1998. Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment, and diagnosis. Adv. Parasitol. 40:37-85.
57. Griffiths, J. K., R. Balakrishnan, G. Widmer, and S. Tzipori. 1998. Paromomycin and geneticin inhibit intracellular Cryptosporidium parvum without trafficking through the host cell cytoplasm: implications for drug delivery. Infect. Immun. 66:3874-3883.
58. Griffiths, J. K., R. Moore, S. Dooley, G. T. Keusch, and S. Tzipori. 1994. Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death. Infect. Immun. 62:4506-4514.
59. Griffiths, J. K., C. Theodos, M. Paris, and S. Tzipori. 1998. The gamma interferon gene knockout mouse: a highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum. J. Clin. Microbiol. 36: 2503-2508.
60. Hays, M. P., D. A. Mosier, and R. D. Oberst. 1995. Enhanced karyotype resolution of Cryptosporidium parvum by contour-clamped homogeneous electric fields. Vet. Parasitol. 58:273-280.
61. Holmberg, S. D., A. C. Moorman, J. C. VonBargen, M. O. Loveless, D. J. Ward, and T. R. Navin. 1998. Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. JAMA 279:384-386.
62. Hoxie, N. J., J. P. Davis, J. M. Vergeront, R. D. Nashold, and K. A. Blair. 1997. Cryptosporidiosis-associated mortality following a massive waterborne outbreak in Milwaukee, Wisconsin. Am. J. Public Health 87:2032-2035.
63. Janoff, E. N., C. Limas, R. L. Gebhard, and K. A. Penley. 1990. Cryptosporidial carriage without symptoms in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 112:75-76.
64. Jordan, W. C. 1996. Clarithromycin prophylaxis against Cryptosporidium enteritis in patients with AIDS. J. Natl. Med. Assoc. 88:425-427.
65. Keithly, J. S., G. Zhu, S. J. Upton, K. M. Woods, M. P. Martinez, and N. Yarlett. 1997. Polyamine biosynthesis in Cryptosporidium parvum and its implications for chemotherapy. Mol. Biochem. Parasitol. 88:35-42.
66. Khramtsov, N. V., and S. J. Upton. 1998. High-temperature inducible cell-free transcription and replication of double-stranded RNAs within the parasitic protozoan Cryptosporidium parvum. Virology 245:331-337.
67. Khramtsov, N. V., K. M. Woods, M. V. Nesterenko, C. C. Dykstra, and S. J. Upton. 1997. Virus-like, double-stranded RNAs in the parasitic protozoan Cryptosporidium parvum. Mol. Microbiol. 26:289-300.
68. Kim, L. S., W. K. Hartley, J. Stansell, J. P. Cello, and J. Koch. 1998. Declining prevalence of cryptosporidiosis in San Francisco. Clin. Infect. Dis. 27:655-656.
69. Kohler, S., C. F. Delwiche, P. W. Denny, L. G. Tilney, P. Webster, R. J. M. Wilson, J. D. Palmer, and D. S. Roos. 1997. A plastid of probable green algal origin in apicomplexan parasites. Science 275:1485-1489.
70. Laurent, F., L. Eckmann, T. Savidge, G. Morgan, C. Theodos, M. Naciri, and M. Kagnoff. 1997. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect. Immun. 65:5067-5073.
71. 2α production. Infect. Immun. 66:1787-1790.
72. Laxer, M. L., B. K. Timblin, and R. J. Patel. 1991. DNA sequences for the specific detection of Cryptosporidium parvum by the polymerase chain reaction. Am. J. Trop. Med. Hyg. 45:688-694.
73. LeBlancq, S. M., N. V. Khramtsov, F. Zamani, S. J. Upton, and T. W. Wu. 1997. Ribosomal RNA gene organization in Cryptosporidium parvum. Mol. Biochem. Parasitol. 90:463-478.
74. LeChevallier, M. W., and W. D. Norton. 1995. Giardia and Cryptosporidium in raw and finished water. J. Am. Water Works Assoc. 87(Sept.):54-68.
75. Lefkowitch, J. H., S. Krumholz, K.-C. Feng-Chen, P. Griffin, D. Despommier, and T. A. Brasitus. 1984. Cryptosporidiosis of the human small intestine: a light and electron microscopic study. Hum. Pathol. 15:746-752.
76. Lemoing, V., F. Bissuel, D. Costagliola, Z. Eid, F. Chapuis, J. M. Molina, D. Salmonceron, P. Brasseur, and C. Leport. 1998 Decreased prevalence of intestinal Cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors. AIDS 12:1395-1397.
77. Leng, X., D. A. Mosier, and R. D. Oberst. 1996. Simplified method for recovery and PCR detection of Cryptosporidium DNA from bovine feces. Appl. Environ. Microbiol. 62:643-647.
78. Lima, A. A. M., G. Fang, J. B. Schorlin, L. de Albuquerque, J. F. McAuliffe, S. Mota, R. Leite, and R. L. Guerrant. 1992. Persistent diarrhea in Northeast Brazil: etiologies and interactions with malnutrition. Acta Paediatr. Suppl. 361:39-44.
79. Lumadue, J. A., Y. C. Manabe, R. D. Moore, P. C. Belitsos, C. L. Sears, and D. P. Clark. 1998. A clinicopathologic analysis of AIDS-related cryptosporidiosis. AIDS. 12:2459-2466.
80. Macfarlane, D. E., and J. Horner-Bryce. 1987. Cryptosporiodiosis in well nourished and malnourished children. Acta Paediatr. Scand. 76:474-477.
81. MacKenzie, W. R., W. L. Schell, K. A. Blair, D. G. Addiss, D. E. Peterson, N. J. Hoxie, J. J. Kazmierczak, and J. P. Davis. 1995. Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin. Infect. Dis. 21:57-62.
82. MacPherson, D. W., and R. McQueen. 1993. Cryptosporidiosis: Multiattribute evaluation of six diagnostic methods. J. Clin. Microbiol. 31:198-202.
83. Manabe, Y. C., D. P. Clark, R. D. Moore, J. A. Lumadue, H. R. Dahlman, P. C. Belitsos, R. E. Chaisson, and C. L. Sears. 1998. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin. Infect. Dis. 27:536-542.
84. Marshall, M. M., D. Naumovitz, Y. Ortega, and C. R. Sterling. 1997. Waterborne protozoan pathogens. Clin. Microbiol. Rev. 10:67-85.
85. McAnulty, J. M., D. W. Fleming, and A. H. Gonzalez. 1994. A community-wide outbreak of Cryptosporidiosis associated with swimming at a wave pool. JAMA 272:1597-1600.
86. McDonald, V., and G. J. Bancroft. 1994. Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol. 16:315-320.
87. McDonald, V., R. Deer, S. Uni, M. Iseki, and G. J. Bancroft. 1992. Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice. Infect. Immun. 60:3325-3331.
88. McFadden, G. I., M. E. Reith, J. Munholland, and N. Lang-Unnasch. 1996. Plastid in human parasites. Nature 381:482.
89. McGowan, I., A. S. Hawkins, and I. V. D. Weller. 1993. The natural history of cryptosporidial diarrhoea in HIV-infected patients. AIDS 7:349-354.
90. Mead, J. R., R. C. Humphreys, D. W. Sammons, and C. R. Sterling. 1990. Identification of isolate-specific sporozoite proteins of Cryptosporidium parvum by two-dimensional gel electrophoresis. Infect. Immun. 58:2071-2075.
91. Mead, J. R., and X. D. You. 1998. Susceptibility differences to Cryptosporidium parvum infection in two strains of gamma interferon knockout mice. J. Parasitol. 84:1045-1048.
92. Millard, P. S., K. F. Gensheimer, D. G. Addiss, D. M. Sosin, G. A. Beckett, A. Houck-Jankoski, and A. Hudson. 1994. An outbreak of cryptosporidiosis from fresh-pressed apple cider. JAMA 272:1592-1596.
93. Miller, J. R. 1998. Decreasing cryptosporidiosis among HIV-infected persons in New York City, 1995-1997. J. Urban Health 75:601-602.
94. Molbak, K., M. Andersen, P. Aaby, N. Hojlyng, M. Jakobsen, M. Sodemann, and A. P. J. daSilva. 1997. Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, West Africa. Am. J. Clin. Nutr. 65:149-152.
95. Moore, R., S. Tzipori, J. K. Griffiths, K. Johnson, L. DeMontigny, and I. Lomakina. 1995. Temporal changes in permeability and structure of piglet ileum after site-specific infection by Cryptosporidium parvum. Gastroenterology 108:1030-1039.
96. Morgan, U. M., C. C. Constantine, D. A. Forbes, and R. C. A. Thompson. 1997. Differentiation between human and animal isolates of Cryptosporidium parvum using rDNA sequencing and direct PCR analysis. J. Parasitol. 83:825-830.
97. Morgan, U. M., C. C. Constantine, P. O'Donoghue, B. P. Meloni, P. A. O'Brien, and R. C. A. Thompson. 1995. Molecular characterization of Cryptosporidium isolates from humans and other animals using random amplified polymorphic DNA analysis. Am. J. Trop. Med. Hyg. 52:559-564.
98. Morgan, U. M., P. A. O'Brien, and R. C. A. Thompson. 1996. The development of diagnostic PCR primers for Cryptosporidium using RAPD-PCR. Mol. Biochem. Parasitol. 77:103-108.
99. Morgan, U. M., L. Pallant, B. W. Dwyer, D. A. Forbes, G. Rich, and R. C. A. Thompson. 1998. Comparison of PCR and microscopy for detection of Cryptosporidium parvum in human fecal specimens: clinical trial. J. Clin. Microbiol. 36:995-998.
100. Morgan, U. M., K. D. Sargent, P. Deplazes, D. A. Forbes, F. Spano, H. Hertzberg, A. Elliot, and R. C. A. Thompson. 1998. Molecular characterization of Cryptosporidium from various hosts. Parasitology 117:31-37.
101. Morgan, U. M., and R. C. A. Thompson. 1998. PCR detection of Cryptosporidium: the way forward? Parasitol. Today 14:241-246.
102. Moss, D. M., C. L. Chappell, P. C. Okhuysen, H. L. DuPont, M. J. Arrowood, A. W. Hightower, and P. J. Lammie. 1998. The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans. J. Infect. Dis. 178:827-833.
103. Neill, M. A., S. K. Rice, N. V. Admad, and T. P. Flanigan. 1996. Cryptosporidiosis: an unrecognized cause of diarrhea in elderly hospitalized patients. Clin. Infect. Dis. 22:168-170.
104. Newman, R. D., T. Wuhib, A. A. M. Lima, R. L. Guerrant, and C. L. Sears. 1993. Environmental sources of Cryptosporidium in an urban slum in Northeastern Brazil. Am. J. Trop. Med. Hyg. 49:270-275.
105. Newman, R. D., S.-X. Zu, T. Wuhib, A. A. M. Lima, R. L. Guerrant, and C. L. Sears. 1994. Household epidemiology of Cryptosporidium parvum infection in an urban community in Northeast Brazil. Ann. Intern. Med. 120:500-505.
106. Nichols, G. L., J. McLauchlin, and D. Samuel. 1991. A technique for typing Cryptosporidium isolates. J. Protozool. 38:237S-240S.
107. Nina, J. M., V. McDonald, R. M. A. Deer, S. E. Wright, D. A. Dyson, P. L. Chiodini, and K. P. W. J. McAdam. 1992. Comparative study of the antigenic composition of oocyst isolates of Cryptosporidium parvum from different hosts. Parasite Immunol. 14:227-232.
108. Novak, S. M., and C. R. Sterling. 1991. Susceptibility dynamics in neonatal BALB/c mice infected with Cryptosporidium parvum. J. Protozool. 38:102S-104S.
109. Okhuysen, P. C., C. L. Chappell, C. R. Sterling, and H. L. DuPont. 1997. Virulence of three distinct C. parvum isolates in healthy adults, abstr. 396. In 35th Annual Meeting of the Infectious Diseases Society of America.
110. Okhuysen, P. C., C. L. Chappell, C. R. Sterling, W. Jakubowski, and H. L. DuPont. 1998. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect. Immun. 66:441-443.
111. Ortega, Y. R., R. R. Sheehy, V. A. Cama, K. K. Oishi, and C. R. Sterling. 1991. Restriction fragment length polymorphism analysis of Cryptosporidium parvum isolates of bovine and human origin. J. Protozool. 38:40S-41S.
112. Palella, F. J., K. M. Delaney, A. C. Moorman, M. O. Loveless, J. Fuhrer, G. A. Satten, D. J. Aschman, and S. D. Holmberg. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338:853-860.
113. Peng, M. P., L. Xiao, A. R. Freeman, M. J. Arrowood, A. A. Escalante, A. C. Weltman, C. S. L. Ong, W. R. MacKenzie, A. A. Lal, and C. B. Beard. 1997. Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg. Infect. Dis. 3:567-573.
114. Perryman, L. E., P. H. Mason, and C. E. Chrisp. 1994. Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice. Infect. Immun. 62:1474-1477.
115. Petersen, C. 1992. Cryptosporidiosis in patients infected with the human immunodeficiency virus. Clin. Infect. Dis. 15:903-909.
116. Piper, M. B., A. T. Bankier, and P. H. Dear. 1998. Construction and characterisation of a genomic PAC library of the intestinal parasite Cryptosporidium parvum. Mol. Biochem. Parasitol. 95:147-151.
117. Pitlik, S. D., V. Fainstein, D. Garza, L. Guarda, R. Bolivar, A. Rios, R. L. Hopfer, and P. A. Mansell. 1983. Human Cryptosporidiosis: spectrum of disease. Report of six cases and review of the literature. Arch. Intern. Med. 143:2269-2275.
118. Pozio, E., M. A. G. Morales, F. M. Barbieri, and G. La Rosa. 1992. Cryptosporidium: different behavior in calves of isolates of human origin. Trans. R. Soc. Trop. Med. Hyg. 86:636-638.
119. Pozio, E., G. Rezza, A. Boschini, P. Pezzotti, A. Tamburrini, P. Rossi, M. Di Fine, C. Smacchia, A. Schiesare, and E. Gattei. 1997. Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former infection drug users. J. Infect. Dis. 176:969-975.
120. Ramratnam, B., and T. P. Flanigan. 1997. Cryptosporidiosis in persons with HIV infection. Postgrad. Med. J. 73:713-716.
121. Ranucci, L., H. Muller, G. LaRosa, I. Reckman, M. A. G. Morales, F. Spano, E. Pozio, and A. Crisanti. 1993. Characterization and immunolocalization of a Cryptosporidium protein containing repeated amino acid motifs. Infect. Immun. 61:2347-2356.
122. Roberts, F., C. W. Roberts, J. J. Johnson, D. E. Kyle, T. Krell, J. R. Coggins, G. H. Coombs, W. K. Milhous, S. Tzipori, and D. J. P. Ferguson. 1998. Evidence for the shikimate pathway in apicomplexan parasites. Nature. 393:801-805.
123. Rohlman, V. C., T. L. Kuhis, D. A. Mosier, D. L. Crawford, and R. A. Greenfield. 1993. Cryptosporidium parvum infection after abrogation of natural killer cell activity in normal and severe combined immunodeficiency mice. J. Parasitol. 79:295-297.
124. Rossi, P., F. Rivasi, M. Codeluppi, A. Catania, A. Tamburrini, E. Righi, and E. Pozio. 1998. Gastric involvement in AIDS associated cryptosporidiosis. Gut 43:476-477.
125. Sallon, S., R. J. Deckelbaum, I. I. Schmid, S. Harlap, M. Baras, and D. T. Spira. 1988. Cryptosporidium, malnutrition, and chronic diarrhea in children. Am. J. Dis. Child. 142:312-315.
126. Saltzberg, D. M., K. L. Kotloff, J. L. Newman, and R. Fastiggi. 1991. Cryptosporidium infection in acquired immunodeficiency syndrome: not always a poor prognosis. J. Clin. Gastroenterol. 13:94-97.
127. Sarabia-Arce, S., E. Salazar-Lindo, R. H. Gilman, J. Naranjo, and E. Miranda. 1990. Case-control study of Cryptosporidium parvum infection in Peruvian children hospitalized for diarrhea: possible association with malnutrition and nosocomical infection. Pediatr. Infect. Dis. J. 9:627-631.
128. Seydel, K. B., T. Zhang, G. A. Champion, C. Fichtenbaum, P. E. Swanson, S. Tzipori, J. K. Griffiths, and J. Stanley. 1998. Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8. Infect. Immun. 66:2379-2382.
129. Smith, H. V., and J. B. Rose. 1998. Waterbourne cryptosporidiosis: current status. Parasitol. Today. 14:14-22.
130. Smith, N. H., S. Cron, L. M. Valdez, C. L. Chappell, and A. C. White. 1998. Combination drug therapy for cryptosporidiosis in AIDS. J. Infect. Dis. 178:900-903.
131. Spano, F., L. Putignani, A. Crisanti, P. Sallicandro, U. M. Morgan, S. M. LeBlancq, L. Tchack, S. Tzipori, and G. Widmer. 1998. A multilocus genotypic analysis of Cryptosporidium parvum from different hosts and geographical origin. J. Clin. Microbiol. 36:3255-3259.
132. Spano, F., L. Putignani, S. Guida, and A. Crisanti. 1998. Cryptosporidium parvum: PCR-RFLP analysis of the TRAP-C1 (thrombospondin-related adhesive protein of Cryptosporidium-1) gene discriminates between two alleles differentially associated with parasite isolates of animal and human origin. Exp. Parasitol. 90:195-198.
133. Spano, F., L. Putignani, J. McLauchlin, D. P. Casemore, and A. Crisanti. 1997. PCR-RFLP analysis of Cryptosporidium oocyst wall protein (COWP) gene discriminates between C. wrairi and C. parvum, and between C. parvum isolates of human and animal origin. FEMS Microbiol. Lett. 150:209-217.
134. Stockman, M., M. Fromm, H. Schmitz, W. Schmidt, E.-O. Riecken, and J.-D. Schulzke. 1998. Duodena biopsies of HIV-infected patients with diarrhoea exhibit epithelial barrier defects but no active secretion. AIDS 12:43-51.
135. Sulaiman, I., L. Xiao, C. Yang, L. Escalente, A. Moore, C. Beard, M. Arrowood, and A. Lal. 1998. Differentiating human from animal isolates of Cryptosporidium parvum. Emerg Infect. Dis. 4:681-685.
136. Taghi-Kilani, R., and L. Sekla. 1987. Purification of Cryptosporidium parvum oocysts and sporozoites by cesium chloride and percoll gradients. Am. J. Trop. Med. Hyg. 36:505-508.
137. Travis, W. D., K. Schmidt, J. D. MacLowry, H. Masur, K. S. Condron, and A. T. Fojo. 1990. Respiratory cryptosporidiosis in a patient with malignant lymphoma. Report of a case and review of the literature. Arch. Pathol. Lab. Med. 114:519-522.
138. Tzipori, S. 1983. Cryptosporidiosis in animals and humans. Microbiol. Rev. 47:84-96.
139. Tzipori, S. 1988. Cryptosporidiosis in perspective. Adv. Parasitol. 27:63-129.
140. Tzipori, S. 1998. Cryptosporidiosis: laboratory investigations and chemotherapy. Adv. Parasitol. 40:187-221.
141. Tzipori, S., and J. K. Griffiths. 1998. Natural history and biology of Cryptosporidium parvum. Adv. Parasitol. 40:6-36.
142. Ungar, B. L. P., T.-C. Kao, J. A. Burris, and F. D. Finkelman. 1991. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-γ and CD4+ T lymphocytes in protective immunity. J. Immunol. 147:1014-1022.
143. Urban, J. F., Jr., R. Fayer, S-J. Chen, W. C. Gause, M. K. Gately, and F. D. Finkelman. 1996. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J. Immunol. 156:263-268.
144. Vakil, N. B., S. M. Schwartz, B. P. Buggy, C. F. Brummitt, M. Kherellah, D. M. Letzer, I. H. Gilson, and P. G. Jones. 1996. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N. Eng. J. Med. 334:19-23.
145. Valdez, H., D. Durke, S. M. Gordon, K. A. Adal, J. H. Johnson, and P. M. Wiest. 1998. Survival of AIDS patients with cryptosporidiosis. Infect. Dis. Clin. Pract. 7:157-160.
146. Vasquez, J. R., L. Gooze, K. Kim, J. Gut, C. Petersen, and R. G. Nelson. 1996. Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum. Mol. Biochem. Parasitol. 79:153-165.
147. Ventura, G., R. Cauda, L. M. Larocca, M. E. Riccioni, M. Tumbarello, and M. B. Lucia. 1997. Gastric Cryptosporidiosis complicating HIV infection: case report and review of the literature. Eur. J. Gastroenterol. Hepatol. 9:307-310.
148. Waters, W. R., and J. A. Harp. 1996. Cryptosporidium parvum infection in T-cell receptor (TCR)-α- and TCR-γ-deficient mice. Infect. Immun. 64: 1854-1857.
149. Webster, K. A., J. D. E. Pow, M. Giles, J. Catchpole, and M. J. Woodward. 1993. Detection of Cryptosporidium parvum using a specific polymerase chain reaction. Vet. Parasitol. 50:35-44.
150. Welsh, J., and M. McClelland. 1993. Characterization of pathogenic microorganisms by genomic fingerprinting using arbitrarily primed PCR, p. 595-602. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
151. Widmer, G. 1998. Genetic heterogeneity and PCR detection of Cryptosporidium parvum. Adv. Parasitol. 40:223-240.
152. Widmer, G., L. Tchack, C. L. Chappell, and S. Tzipori. 1998. Sequence polymorphism in the β-tubulin gene reveals heterogeneous and variable population structures in Cryptosporidium parvum. Appl. Environ. Microbiol. 64:4477-4481.
153. Widmer, G., S. Tzipori, C. J. Fichtenbaum, and J. K. Griffiths. 1998. Genotypic and phenotype characterization of Cryptosporidium parvum isolates from people with AIDS. J. Infect. Dis. 178:834-840.
154. Zar, F., P. J. Geeseler, and V. A. Brown. 1985. Asymptomatic carriage of Cryptosporidium in the stool of a patient with acquired immunodeficiency syndrome. J. Infect. Dis. 151:195.
155. Zhu, G., M. J. Marchewka, J. G. Ennis, and J. S. Keithly. 1998. Direct isolation of DNA from patient stools for polymerase chain reaction detection of Cryptosporidium parvum. J. Infect. Dis. 177:1443-1446.